Advanced Glycation End Product (AGE) Antibody

Este producto es parte de AGE - Advanced Glycation End Product (Receptor)
Advanced Glycation End Product (AGE) Antibody
299€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Advanced Glycation End Product (AGE) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx131709
Tested Applications
WB, IHC, IF/ICC

Description

Advanced Glycation End Product (AGE) Antibody is a Mouse Monoclonal against Advanced Glycation End Product (AGE).

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Advanced Glycation End Product (AGE)
Immunogen: abx168580 - Native AGE Protein.
Host
Mouse
Reactivity
General
Assay Type
Concentration: 1 mg/ml
Recommended Dilution
WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC: 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG2a Kappa
Clone ID
T453
Purification
Purified by Protein A and Protein G affinity chromatography.
Size 1
100 µl
Size 2
200 µl
Size 3
1 ml
Form
Liquid
Tested Applications
WB, IHC, IF/ICC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
Alias
AGE
Background
Antibody anti-AGE
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

Advanced Glycation End Products (AGEs) are a diverse group of molecules formed through the non-enzymatic reaction of reducing sugars with proteins, lipids, or nucleic acids in a process called glycation. AGEs accumulate under conditions of oxidative stress and hyperglycemia, particularly in diseases like diabetes mellitus, where they are formed in excess. They are commonly found in long-lived proteins such as collagen and elastin, contributing to tissue stiffness and organ dysfunction. AGEs can crosslink proteins, disrupt cellular signaling, and impair extracellular matrix structure. They are also known to interact with specific receptors, such as the AGE receptor (AGER), activating inflammatory and oxidative pathways that lead to chronic conditions such as cardiovascular disease, kidney damage, and neurodegeneration. AGEs are considered major contributors to aging and the progression of age-related diseases, making them significant biomarkers and therapeutic targets.

Productos relacionados

abx168580

Human Advanced Glycation End Product (AGE) Protein

Advanced Glycation End Products (AGEs) are the result of a chain of chemical reactions after an initial glycation reacti…

Ver producto